Forepont Capital Partners is a New York-headquartered venture fund with a European presence, run by a team with backgrounds in institutional asset management and private equity, and it sources deals through close ties with researchers, hospitals, academia, and large pharmaceutical companies. The fund has focused on neurotechnology and brain-computer interfaces, favoring less invasive approaches like Synchron's stent-based method and Precision Neuroscience's thin implant, while also backing hardware-heavy medical devices such as Basecamp Vascular's mechatronic guidewire.